- Grants
- Loans & Scholarships
- Data Warehouse
- Training & TA Hub
- Behavioral Health
- Care Teams
- Child and Adolescent Health
- Chronic and Infectious Diseases
- Financing
- Health Information Technology
- HIV/AIDS
- Maternal Health
- Older Adult Health
- Oral Health
- Performance Measurement & Quality Improvement
- Research
- Rural Health
- Social Determinants of Health
- Telehealth
- Training Centers
- Workforce
- About HRSA
FAQs for COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment and Vaccine Administration
Catalog of Federal Domestic Assistance number (CFDA): 93.461
Compliance Questions
Payments received from the program are claims reimbursements and should be treated in the same manner as reimbursements received from commercial insurance, Medicaid, and/or Medicare, including in how revenue or losses are determined. See guidance issued by the Centers for Medicare & Medicaid Services (PDF – 1.1 MB) on how providers should report claims reimbursed through the HRSA COVID-19 Uninsured Program on the S-10 worksheet.
Connect with HRSA
